Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Women left out

• Age limit under 65

  Older women were turned away, even though they often take this medicine.

  “Maximum age: 17 Years.”

• No pregnant women

  Women who were pregnant could not join.

  “The female subject is pregnant or lactating.”

• No breastfeeding moms

  Women who were breastfeeding could not join.

  “The female subject is pregnant or lactating.”

• Had to use birth control

  Women who couldn't or didn't want to use birth control were turned away.

  “…tive serum beta Human Chorionic Gonadotropin (HCG) pregnancy test at Screening and a negative urine pregnancy test at Baseline and agree to use acceptable contraceptives throughout the study period and for 30 days after the last dose of IP.”

• No seizures

  Women with epilepsy or past seizures were turned away.

  “Subject has a history of seizures during the last 2 years, a tic disorder, a current diagnosis and/or family history of Tourette's Disorder.”

• No mental health conditions

  Women with depression, bipolar disorder or other mental health conditions were turned away.

  “…medication) or uncontrolled, with significant symptoms such as Post Traumatic Stress Disorder, psychosis, bipolar illness, pervasive developmental disorder, severe obsessive compulsive disorder, severe depressive or severe anxiety disorder.”

• No cancer

  Women with current or past cancer were turned away.

  “Subject has any skin disease, or history of any chronic skin disease, skin cancer, skin manifestations of allergic disease, or other dermatologic conditions which would interfere with trial assessments or compromise subject safety (e.g. der…”

Study titles and rules are shown in their original English.